BNDES has BRL 1.60bn to invest in the pharmaceutical industry until 2017
BNDES tem BRL 1,6bi para emprestar até 2017 para a indústria farmacêutica
Intel ID : 221915
| Synopsis |
|
Profarma, a program to support the pharmaceutical industry controlled by BNDES, has BRL 1.60bn to lend until 2017. These resources should be used to finance biotechnology projects, among other purposes.
(content in portuguese)
O profarma, programa de apoio à indústria farmacêutica do BNDES tem BRL 1,6bi para emprestar até 2017. Os recursos, entre outros propósitos, são para financiar projetos em biotecnologia. |
| Intel ID | 221915 | ||
| Value | EUR 524,54m | ||
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
||
|
Financial Data - BNDES
(31 Dec 2023) |
Revenue: EUR 10.687,16m Exchange Rate:
|
||
| Date |
 |
||
| Country | |
||
| Region | |||
| Continent | |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Financing Bank
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.01.05 Corporate, Sovereign & Trade Finance 25 Financial Services / 25.01 Banking & Investment |
||
| Secondary Sectors (TTRSC) |
25.01.08 Investment Banking & Brokerage Services 25 Financial Services / 25.01 Banking & Investment |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.